China Includes Two Shanghai Junshi Biosciences Drugs in List of Insurance-Backed Drugs - Marketscreener.com
688180 Stock | 26.58 0.19 0.71% |
About 61% of Shanghai Junshi's investor base is looking to short. The analysis of the overall investor sentiment regarding Shanghai Junshi Biosciences suggests that many traders are alarmed. The current market sentiment, together with Shanghai Junshi's historical and current headlines, can help investors time the market. In addition, many technical investors use Shanghai Junshi Bios stock news signals to limit their universe of possible portfolio assets.
Shanghai |
China Includes Two Shanghai Junshi Biosciences Drugs in List of Insurance-Backed Drugs Marketscreener.com
Read at news.google.com
Shanghai Junshi Fundamental Analysis
We analyze Shanghai Junshi's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Shanghai Junshi using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Shanghai Junshi based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Working Capital
Working Capital Comparative Analysis
Shanghai Junshi is currently under evaluation in working capital category among its peers. Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
Shanghai Junshi Bios Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Shanghai Junshi stock to make a market-neutral strategy. Peer analysis of Shanghai Junshi could also be used in its relative valuation, which is a method of valuing Shanghai Junshi by comparing valuation metrics with similar companies.
Peers
Shanghai Junshi Related Equities
180101 | Bosera CMSK | 1.48 | ||||
000637 | Maoming Petro | 2.44 | ||||
000949 | Xinxiang Chemical | 4.76 | ||||
603219 | Ningbo Fujia | 5.10 | ||||
002246 | North Chemical | 5.23 | ||||
600490 | Pengxin International | 5.47 | ||||
002295 | Guangdong Jingyi | 5.88 | ||||
000635 | Ningxia Younglight | 6.11 |
Complementary Tools for Shanghai Stock analysis
When running Shanghai Junshi's price analysis, check to measure Shanghai Junshi's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Shanghai Junshi is operating at the current time. Most of Shanghai Junshi's value examination focuses on studying past and present price action to predict the probability of Shanghai Junshi's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Shanghai Junshi's price. Additionally, you may evaluate how the addition of Shanghai Junshi to your portfolios can decrease your overall portfolio volatility.
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Content Syndication Quickly integrate customizable finance content to your own investment portal |